Flputnam Investment Management Co. Takes Position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Flputnam Investment Management Co. acquired a new position in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 7,862 shares of the company’s stock, valued at approximately $327,000.

A number of other institutional investors also recently added to or reduced their stakes in XPH. Envestnet Portfolio Solutions Inc. acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the third quarter worth $1,938,000. Bank of America Corp DE increased its position in SPDR S&P Pharmaceuticals ETF by 16.1% during the 4th quarter. Bank of America Corp DE now owns 323,407 shares of the company’s stock valued at $13,244,000 after buying an additional 44,871 shares in the last quarter. JPMorgan Chase & Co. increased its position in SPDR S&P Pharmaceuticals ETF by 72.9% during the 2nd quarter. JPMorgan Chase & Co. now owns 104,298 shares of the company’s stock valued at $4,380,000 after buying an additional 43,959 shares in the last quarter. LPL Financial LLC raised its stake in SPDR S&P Pharmaceuticals ETF by 26.4% in the third quarter. LPL Financial LLC now owns 124,782 shares of the company’s stock valued at $4,960,000 after buying an additional 26,031 shares during the last quarter. Finally, Wells Fargo & Company MN boosted its holdings in SPDR S&P Pharmaceuticals ETF by 30.0% in the fourth quarter. Wells Fargo & Company MN now owns 82,761 shares of the company’s stock worth $3,389,000 after acquiring an additional 19,091 shares in the last quarter.

SPDR S&P Pharmaceuticals ETF Stock Down 1.2 %

XPH opened at $39.10 on Friday. The company has a market cap of $191.59 million, a P/E ratio of 14.45 and a beta of 0.87. The firm’s 50-day moving average price is $42.98 and its 200-day moving average price is $40.55. SPDR S&P Pharmaceuticals ETF has a 52-week low of $34.67 and a 52-week high of $45.62.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.